The cost of a single capsule may not look high within the overall product.

But once production starts, capsules can have a significant impact: whether they run smoothly on the machine, whether locking is stable, whether batches are consistent, whether registration documents are complete, and whether the capsules become brittle or soft during storage and transport. All of these factors affect final product quality and delivery.

Therefore, when choosing a capsule supplier, price certainly matters, but it should not be the only consideration.

As a capsule supplier, we often see customers first ask about price, specifications, and lead time. That is normal. But before entering into real cooperation, we also advise customers to look more closely at several quality details.

For pharmaceutical companies, health supplement brands, and contract manufacturers, the more prudent approach is to treat capsules as critical packaging materials that directly affect product quality. The following six questions should be clarified in advance when selecting a supplier.

1. Raw Material Control: Quality Problems Often Do Not Begin with the Finished Product

The first checkpoint for capsule quality is raw materials.

For gelatin capsules, attention should be paid to gelatin source, supplier management, microbiological indicators, heavy metals, and other parameters. For HPMC capsules, the stability of cellulose raw materials and key excipients should be reviewed. For pullulan capsules, the focus should be on whether the raw material source, film-forming properties, and barrier performance are stable.

If a supplier only says that its products “meet the standard” but cannot clearly explain how raw materials are accepted, how suppliers are evaluated, or how abnormal batches are handled, caution is needed.

A truly stable capsule supply is not achieved by sorting products at the end. It starts with control from the moment raw materials enter the factory.

We recommend that procurement or quality teams focus on confirming:

- Whether there is a mechanism for raw material supplier evaluation and re-evaluation

- Whether each batch of raw materials has acceptance criteria and testing records

- Whether risk assessment is conducted and customers are notified when raw materials change

- Whether necessary quality documents and traceability information can be provided

The requirements of China’s National Medical Products Administration for drug manufacturing quality management also clearly mention that pharmaceutical manufacturers should evaluate suppliers or manufacturers of supplied materials to ensure that their sources and use comply with regulatory requirements. Although a capsule is only a small packaging material, it is in direct contact with the contents and should not be treated as ordinary outer packaging.

2. Batch-to-Batch Consistency: A Good Sample Does Not Mean Every Bulk Batch Will Be Good

Many customers first look at samples when choosing capsules for the first time. As a supplier, we also welcome sample testing, because samples help both sides determine early whether the specification, material, and contents are compatible.

It is certainly a good sign if the sample looks good and filling tests run smoothly. But a sample only reflects the performance of one batch at one stage. The real test of a supplier is whether every subsequent bulk batch can remain stable.

Capsule batch consistency is reflected in many details:

- Whether dimensions remain stable

- Whether moisture remains stable

- Whether brittleness remains stable

- Whether the tightness of locking remains stable

- Whether filling performance on the machine remains stable

- Whether there is obvious color deviation between batches

If batch variation is large, customers may experience frequent machine adjustments, cap separation, dents, fill-weight variation, and inconsistent appearance on site. These may appear to be production efficiency problems, but the underlying cause may actually be insufficient stability of the packaging material.

Therefore, when choosing a capsule supplier, do not only ask whether the supplier can make the product. Also ask whether it can make the product consistently over the long term.

3. Testing Capability: Products Should Not Leave the Factory Just Because They Have Been Made

Empty capsules should not be shipped immediately after production is completed. As a supplier, we believe there should be a clearly defined quality testing and release process before shipment.

Common items to review include:

- Appearance

- Dimensions

- Moisture

- Brittleness

- Disintegration time

- Microbial limits

- Heavy metals, residues, or other safety-related indicators, tested according to applicable standards and customer requirements

- Functional evaluation for special capsules, such as enteric performance, barrier performance studies, or suitability verification

The key point here is not simply whether testing equipment is available, but whether testing has become a system: whether there are clear standards, retained samples, complete records, and a deviation-handling process.

Customers can ask suppliers directly:

- Whether every batch has an inspection report

- Whether test methods have been confirmed or validated

- How nonconforming batches are handled

- Whether there is a retained-sample and traceability mechanism

- Whether the supplier can cooperate with customer audits

If the answers to these questions are vague, even a low quotation may not represent real value.

4. Production Process: Capsule Stability Comes from Process Control, Not Slogans

Capsule quality cannot be explained by simply saying “strict quality control.”

What customers really need to see is whether the supplier has implemented quality control throughout the production process. For a supplier, quality is not created only in the testing laboratory; it is controlled step by step during production.

For example:

- Whether workshop temperature and humidity are controlled

- Whether key process parameters are recorded

- Whether there are procedures for equipment cleaning and maintenance

- Whether in-process inspections are carried out

- Whether abnormalities can be identified and handled in a timely manner

- Whether complete production records exist for different batches

These details may seem basic, but they determine whether capsule quality can be reproduced consistently.

Relevant GMP requirements issued by China’s National Medical Products Administration state that pharmaceutical manufacturing quality management should cover all factors affecting drug quality, and that production processes, testing, deviations, and records should be traceable. For suppliers of packaging materials that come into direct contact with drugs, corresponding process control and traceability capabilities should also be established around customer quality requirements.

In other words, a good capsule supplier does more than make the product. It can explain to customers how the product is made consistently.

5. Documentation Support: Audits, Registration, and Export Projects All Depend on It

Many customers focus only on samples and quotations in the early stage, and only discover incomplete documentation when registration, audits, or customer factory inspections begin.

That puts them in a very passive position.

Whether a capsule supplier can provide complete, standardized, and traceable documentation directly affects the customer’s subsequent project progress. This is especially important for pharmaceutical customers, functional food customers, and brands entering overseas markets.

From the supplier’s perspective, documentation support should not be a matter of temporarily supplementing materials. It should be part of routine quality management.

Key items to review include:

- Product quality standards

- Inspection reports

- Raw material and production-related descriptions

- Batch traceability records

- Stability or suitability data

- Change notification mechanism

- Necessary compliance or registration documents

For drug registration in China, chemical active pharmaceutical ingredients, excipients, and packaging materials that come into direct contact with drugs are subject to associated review together with the drug product. In other words, packaging materials do not exist in isolation; they are included in the overall drug quality evaluation system.

Therefore, documentation capability is not an “additional service.” It is part of the supplier’s capability.

6. Technical Service: When Problems Occur, Can the Supplier Investigate Together?

Once production reaches the customer’s site, problems are often not caused by a single factor.

For example, unstable capsule performance on the filling machine may be related to capsule moisture, locking, or dimensions. It may also be related to powder flowability, equipment speed, filling parameters, or workshop humidity.

If a supplier only says, “There is no problem with our capsules,” it is difficult for the customer to move the issue forward. The approach we recognize more is to look at the capsule, contents, equipment, and site environment together.

A more valuable supplier should be able to review problems together with the customer:

- What are the properties of the contents?

- Is the capsule model suitable?

- Is the filling speed too high?

- Are workshop temperature and humidity appropriate?

- Have storage conditions changed?

- Is the problem concentrated in a particular batch, machine, or time period?

In many cases, what customers need is not a single conclusion, but a structured troubleshooting approach.

This is also why capsule suppliers should not be evaluated on price alone. A slightly lower price may lead to higher overall costs if it is followed by frequent downtime, rework, complaints, and revalidation.

A capsule may look like a small packaging material, but behind it are raw materials, processes, testing, registration, production, and the end-user experience.

Price can be negotiated when selecting a supplier, but the quality baseline cannot be compromised.

From the supplier’s perspective, truly stable long-term cooperation cannot rely on a quotation alone. A capsule supplier worthy of customers’ trust should be able to do three things:

First, maintain stable product quality; second, provide clear documentation and records; third, work with customers to solve problems when they arise.

For customers, choosing the right capsule supplier is not only about buying a batch of capsules. It is also about reducing hidden risks in future production stability, quality compliance, and long-term delivery.

This is why we have always advised customers to look more closely at quality details. Price determines whether a purchase can start easily; quality and service determine whether cooperation can continue over the long term.

References:

1. National Medical Products Administration: relevant requirements of the Good Manufacturing Practice for Drugs, including quality management systems, material supplier evaluation, testing and release, and record traceability.

2. National Medical Products Administration: relevant provisions of the Measures for the Administration of Drug Registration, which mention associated review and approval of chemical active pharmaceutical ingredients, excipients, and packaging materials that come into direct contact with drugs together with the drug product.

3. ICH Q10 Pharmaceutical Quality System, which states that the pharmaceutical quality system should cover outsourced activities and purchased material management.

4. National Medical Products Administration: relevant provisions of the Measures for the Supervision and Administration of Drug Manufacturing, which mention that drug marketing authorization holders and manufacturers should evaluate suppliers of packaging materials and containers that come into direct contact with drugs.